.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,360,817

« Back to Dashboard

Summary for Patent: 5,360,817

Title: Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents
Abstract:Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation .and their use in the treatment of viral infections, in particular influenza, are described.
Inventor(s): von Izstein; Laurence M. (North Fitzray, AU), Wu; Wen-Yang (Mount Waverley, AU), Phan; Tho V. (Carnegie, AU), Danylec; Basil (Box Hill, AU), Jin; Betty (Mount Waverley, AU)
Assignee: Biota Scientific Management Pty Ltd (Melbourne, AU)
Application Number:07/946,327
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation;
Patent PDF download available with subscription

No matches for this query

Foreign Priority and PCT Information for Patent: 5,360,817

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPJ9800Apr 24, 1990
AustraliaPK2896Oct 19, 1990
AustraliaPK4537Feb 11, 1991
PCT Information
PCT FiledApril 24, 1991PCT Application Number:PCT/AU91/00161
PCT Publication Date:October 31, 1991PCT Publication Number: WO91/16320

International Patent Family for Patent: 5,360,817

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO)249<disabled in preview>
African Regional IP Organization (ARIPO)9100253<disabled in preview>
Austria161253<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc